exfoliating and smoothing scrub

1. INCI & CAS

INCI: Jojoba Esters · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Jojoba esters are the hydrogenated or solid ester form used as a cosmetic scrub. They are not plastic beads. CAS depends on the ester cut.

3. Typical use levels (formulation guide)

• The level shown for scrubs is 2–8% as a formulation guide.

Add after the emulsion is formed so the particles stay discrete.

4. Regulatory sources & global compliance

• CosIng information about Jojoba Esters does not itself authorize a particular grade or finished cosmetic.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Jojoba Esters is used before the cosmetic is placed on the EU market.
• Review the supplier TDS for the received Jojoba Esters grade, together with the target market's current filing requirements.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it is not evidence of drug approval or OTC authorization and the completed formula still requires stability and patch testing.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; consider an airless or pump format when oxidation sensitivity warrants it; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic concept for Jojoba Esters in this entry centers on jojoba-ester scrub.

• The available ingredient details does not demonstrate claims of drug action or cure, or a product certification outside the supporting records.
• The ingredient note for Jojoba Esters provides no basis for a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.

1. INCI & CAS

INCI: Kaolin · CAS: 1332-58-7

2. Role in the formula

The cosmetic-clay entry is kaolin, or hydrated aluminum silicate. No drug-absorbent claim is made.

3. Typical use levels (formulation guide)

• 5–20% is listed for masks for the formula.
• The level shown for scrubs is 2–8%.

Wet the clay before adding to a gum phase to limit clumps.

4. Regulatory sources & global compliance

• CosIng may identify Kaolin as an ingredient, but its entry does not approve a material grade or finished formula.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety review of the finished cosmetic in which Kaolin is used before the finished product is marketed.
• Review the documentation for the actual Kaolin grade and the filing requirements for the target market.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; no drug approval or OTC-monograph status follows from this guide with patch response and finished-product stability still to be verified.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; review airless or pump options if oxidation presents a concern; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The formulation note describes Kaolin as part of a cosmetic direction focused on kaolin clay.

• The ingredient record cannot substantiate therapeutic results, cure claims, or unverified certification claims.
• This Kaolin listing does not support whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• Gels and serums: 3–8% as a formulation guide.
• For creams, the recorded level is 2–5% in this reference.
• The rinse-off use-level reference is 2–4% as a formulation guide.

Add Glycerin to the water phase; no separate melt step is needed.

4. Regulatory sources & global compliance

• The CosIng record for Glycerin, where listed, is informational rather than product-specific authorization.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety assessment of the finished cosmetic containing Glycerin in the final product context.
• Match the selected Glycerin material to its supplier TDS and check the filing list for the market of sale.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; it provides no evidence that a drug or OTC monograph applies with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; where oxidation is a concern, evaluate airless or pump packaging; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Glycerin emphasizes humectant function.

• The ingredient record does not support medical outcomes, cure language, or a product certification not supported by the available facts.
• The ingredient note for Glycerin is not evidence for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.